NYSE · Healthcare
Stablecoin Development Corp (SDEV)
As-reported financials and recent SEC filings for Stablecoin Development Corp, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
—
Net income
$-630.8M
Net margin
—
Diluted EPS
—
ROE
99.8%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | $9.8M | $10.5M | $14.4M | $10.2M |
| Gross profit | — | $6.5M | $6.1M | $7.8M | $6.5M |
| Operating income | $-8.4M | $-7.4M | $-4.1M | $-14.4M | $-8.9M |
| Net income | $-630.8M | $-7.2M | $-9.6M | $-10.6M | $-5.8M |
| Diluted EPS | — | — | — | — | — |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-17
View on EDGAR →42026-06-17
View on EDGAR →42026-06-17
View on EDGAR →SCHEDULE 13D/A2026-06-17
View on EDGAR →SCHEDULE 13D/A2026-06-17
View on EDGAR →8-K2026-06-17
View on EDGAR →SCHEDULE 13D2026-05-27
View on EDGAR →SCHEDULE 13G2026-05-22
View on EDGAR →Largest Healthcare peers
Go deeper on SDEV
Search Stablecoin Development Corp’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.